Roivant Sciences (ROIV) Change in Acquisitions & Divestments (2020 - 2025)
Roivant Sciences (ROIV) posted Change in Acquisitions & Divestments of $2.7 billion for Q4 2025, up 148.42% on a QoQ basis from $1.1 billion in Q3 2025, and up 185.94% year-over-year from $960.0 million in Q4 2024.
Roivant Sciences (ROIV) Change in Acquisitions & Divestments (2020 - 2025) Analysis & Trends
Roivant Sciences' Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $2.7 billion for Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 185.94% year-over-year to $2.7 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.5 billion (up 476.04% YoY) and the FY2026 annual result came in at $2.2 billion, changed N/A from the prior year.
- Change in Acquisitions & Divestments was $2.7 billion for Q4 2025 at Roivant Sciences, up from $1.1 billion in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $2.7 billion in Q4 2025 and bottomed at $320.2 million in Q4 2021.
- A 3-year average of $1.2 billion and a median of $960.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2021 — Change in Acquisitions & Divestments surged 200.0% — and 2025, when it surged 185.94%.
- Roivant Sciences' Change in Acquisitions & Divestments stood at $320.2 million in 2021, then jumped by 199.84% to $960.0 million in 2024, then jumped by 185.94% to $2.7 billion in 2025.
- Business Quant data shows ROIV's Change in Acquisitions & Divestments at $2.7 billion in Q4 2025, $1.1 billion in Q3 2025, and $720.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Roivant Sciences | 24.10 Bn | 24.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.75 Bn |
| Dec 31, 2025 | 2.75 Bn |
| Sep 30, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.11 Bn |
| Jun 30, 2025 | 720.00 Mn |
| Jun 30, 2025 | 720.00 Mn |
| Dec 31, 2024 | 960.00 Mn |
| Dec 31, 2024 | 960.00 Mn |
| Dec 31, 2021 | 320.17 Mn |
| Dec 31, 2021 | 320.17 Mn |
| Dec 31, 2020 | -320.17 Mn |
| Dec 31, 2020 | -320.17 Mn |